Related references
Note: Only part of the references are listed.Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma
Katerina Malagari et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2016)
TACE vs DEB-TACE: Who wins?
Mario Angelico
DIGESTIVE AND LIVER DISEASE (2016)
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
Antonio Facciorusso et al.
DIGESTIVE AND LIVER DISEASE (2016)
Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma
Alessandro Cucchetti et al.
DIGESTIVE AND LIVER DISEASE (2016)
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma
Antonio Facciorusso et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Transarterial Chemoembolization for Hepatocellular Carcinoma with a New Generation of Beads: Clinical-Radiological Outcomes and Safety Profile
Carlo Spreafico et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
R. Golfieri et al.
BRITISH JOURNAL OF CANCER (2014)
Chemoembolization of Hepatocellular Carcinoma with Hepasphere 30-60 μm. Safety and Efficacy Study
Katerina Malagari et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2014)
Does Drug-Eluting Bead Transcatheter Arterial Chemoembolization Improve the Management of Patients with Hepatocellular Carcinoma? A Meta-Analysis
Shilong Han et al.
PLOS ONE (2014)
Downstaging Disease in Patients with Hepatocellular Carcinoma Outside of Milan Criteria: Strategies Using Drug-eluting Bead Chemoembolization
Tyler J. Green et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Safety and Efficacy of Doxorubicin Drug-eluting Bead Transarterial Chemoembolization in Patients with Advanced Hepatocellular Carcinoma
Hasmukh J. Prajapati et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Enhancement Patterns of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Drug-Eluting Beads on Arterial Phase CT Images: A Pilot Retrospective Study
Woo-Suk Chung et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2012)
Transcatheter Treatment of Hepatocellular Carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical Recommendations
Riccardo Lencioni et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis
Katerina Malagari et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: Lipiodol vs. drug-eluting beads
Boris Guiu et al.
JOURNAL OF HEPATOLOGY (2012)
Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma
Myeong Jun Song et al.
JOURNAL OF HEPATOLOGY (2012)
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
Marta Burrel et al.
JOURNAL OF HEPATOLOGY (2012)
Value of Noncontrast CT Immediately after Transarterial Chemoembolization of Hepatocellular Carcinoma with Drug-eluting Beads
Yosef S. Golowa et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin-eluting beads compared with lipiodol
Francesco Recchia et al.
ONCOLOGY REPORTS (2012)
Local-Regional Treatment of Hepatocellular Carcinoma
Riccardo Lencioni et al.
RADIOLOGY (2012)
Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case-control study of Asian patients
Myeong Jun Song et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Embolization of hepatocellular carcinoma with drug-eluting beads: Doxorubicin tissue concentration and distribution in patient liver explants
Julien Namur et al.
JOURNAL OF HEPATOLOGY (2011)
Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
Rodolfo Sacco et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2011)
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Johannes Lammer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
Gary L. Davis et al.
GASTROENTEROLOGY (2010)
Cancer mortality in the United Kingdom: projections to the year 2025
A. H. Olsen et al.
BRITISH JOURNAL OF CANCER (2008)
Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead (TM)
Katerina Malagari
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Design and endpoints of clinical trials in hepatocellular carcinoma
Josep M. Llovet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: Results of an open-label study of 62 patients
Katerina Malagari et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2008)
Doxorubicin eluting beads -: 2:: methods for evaluating drug elution and in-vitro:in-vivo correlation
M. Victoria Gonzalez et al.
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE (2008)
Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead
Katerina Malagari et al.
ABDOMINAL IMAGING (2008)
A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead
Ronnie T. P. Poon et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Chemoembolization of hepatocellular carcinoma with drug eluting beads:: Efficacy and doxorubicin pharmacokinetics
Maria Varela et al.
JOURNAL OF HEPATOLOGY (2007)
Transcatheter arterial chemoembolization of hepatocellular carcinoma with hepatic arteriovenous shunt after temporary balloon occlusion of hepatic vein
Jong Hyeog Lee et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2007)
Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization
Andrew L. Lewis et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2006)
New intra-arterial drug delivery system for the treatment of liver cancer: Preclinical assessment in a rabbit model of liver cancer
K Hong et al.
CLINICAL CANCER RESEARCH (2006)
DC bead: In vitro characterization of a drug-delivery device for transarterial chemoembolization
AL Lewis et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2006)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Estimating the world cancer burden: GLOBOCAN 2000
DM Parkin et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
